Shell Asset Management’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $238K | Sell |
3,238
-592
| -15% | -$43.5K | 0.01% | 709 |
|
|
2025
Q1 | $437K | Sell |
3,830
-4,680
| -55% | -$534K | 0.02% | 503 |
|
|
2024
Q4 | $429K | Hold |
8,510
| – | – | 0.02% | 545 |
|
|
2024
Q3 | $394K | Buy |
+8,510
| New | +$394K | 0.02% | 579 |
|
|
2024
Q1 | $292K | Sell |
9,001
-911
| -9% | -$29.6K | 0.01% | 690 |
|
|
2023
Q4 | $322K | Sell |
9,912
-2,964
| -23% | -$96.3K | 0.01% | 689 |
|
|
2023
Q3 | $351K | Sell |
12,876
-223
| -2% | -$6.08K | 0.01% | 703 |
|
|
2023
Q2 | $291K | Sell |
13,099
-4,743
| -27% | -$105K | 0.01% | 794 |
|
|
2023
Q1 | $386K | Sell |
17,842
-62
| -0.3% | -$1.34K | 0.02% | 672 |
|
|
2022
Q4 | $364K | Sell |
17,904
-3,732
| -17% | -$75.9K | 0.02% | 691 |
|
|
2022
Q3 | $555K | Sell |
21,636
-5,668
| -21% | -$145K | 0.02% | 522 |
|
|
2022
Q2 | $649K | Buy |
27,304
+48
| +0.2% | +$1.14K | 0.02% | 570 |
|
|
2022
Q1 | $614K | Sell |
27,256
-4,031
| -13% | -$90.8K | 0.01% | 707 |
|
|
2021
Q4 | $619K | Buy |
31,287
+150
| +0.5% | +$2.97K | 0.01% | 798 |
|
|
2021
Q3 | $613K | Sell |
31,137
-1,340
| -4% | -$26.4K | 0.01% | 772 |
|
|
2021
Q2 | $714K | Buy |
32,477
+8,106
| +33% | +$178K | 0.01% | 741 |
|
|
2021
Q1 | $580K | Sell |
24,371
-140
| -0.6% | -$3.33K | 0.01% | 783 |
|
|
2020
Q4 | $641K | Hold |
24,511
| – | – | 0.01% | 677 |
|
|
2020
Q3 | $427K | Hold |
24,511
| – | – | 0.01% | 747 |
|
|
2020
Q2 | $412K | Buy |
+24,511
| New | +$412K | 0.01% | 747 |
|